MedTrace Logo

EEG Characteristics in ECT

NCT04022226 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-10-26

Study results available
· View outcomes & findings →

Summary

The investigators will be examining slow-wave characteristics in depressed patients receiving electroconvulsive therapy (ECT) using direct current electroencephalogram (dcEEG) by anesthesia induction agent.

Conditions

  • Electroconvulsive Therapy
  • Direct Current Electroencephalogram
  • Ketamine
  • Spreadind Depression

Interventions

DRUG

Ketamine

Induction agent that suppresses infra-slow waves

DRUG

Methohexital

Induction agent that does not suppress infra-slow waves

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-10-01
Completion
2020-10-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04022226 on ClinicalTrials.gov